NO20034773D0 - Nye ftalazinoner - Google Patents
Nye ftalazinonerInfo
- Publication number
- NO20034773D0 NO20034773D0 NO20034773A NO20034773A NO20034773D0 NO 20034773 D0 NO20034773 D0 NO 20034773D0 NO 20034773 A NO20034773 A NO 20034773A NO 20034773 A NO20034773 A NO 20034773A NO 20034773 D0 NO20034773 D0 NO 20034773D0
- Authority
- NO
- Norway
- Prior art keywords
- phthalazinones
- new
- new phthalazinones
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
- C07D237/30—Phthalazines
- C07D237/32—Phthalazines with oxygen atoms directly attached to carbon atoms of the nitrogen-containing ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Pulmonology (AREA)
- Neurosurgery (AREA)
- Dermatology (AREA)
- Communicable Diseases (AREA)
- Hospice & Palliative Care (AREA)
- Cardiology (AREA)
- Psychiatry (AREA)
- Oncology (AREA)
- Rheumatology (AREA)
- Virology (AREA)
- Urology & Nephrology (AREA)
- Pain & Pain Management (AREA)
- AIDS & HIV (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Transplantation (AREA)
- Tropical Medicine & Parasitology (AREA)
- Psychology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Ophthalmology & Optometry (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP01110228 | 2001-04-25 | ||
PCT/EP2002/004438 WO2002085906A2 (en) | 2001-04-25 | 2002-04-23 | Phthalazinones derivatives useful as pde4/7 inhibitors |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20034773D0 true NO20034773D0 (no) | 2003-10-24 |
NO20034773L NO20034773L (no) | 2003-12-10 |
Family
ID=8177249
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20034773A NO20034773L (no) | 2001-04-25 | 2003-10-24 | Nye ftalazinoner |
Country Status (22)
Country | Link |
---|---|
US (1) | US7186710B2 (no) |
EP (1) | EP1385848A2 (no) |
JP (1) | JP2004526789A (no) |
KR (1) | KR20040008162A (no) |
CN (1) | CN1503792A (no) |
AU (1) | AU2002317733B2 (no) |
BG (1) | BG108294A (no) |
BR (1) | BR0209149A (no) |
CA (1) | CA2445233A1 (no) |
CZ (1) | CZ299347B6 (no) |
EA (1) | EA200301100A1 (no) |
EE (1) | EE200300514A (no) |
HR (1) | HRP20030868A2 (no) |
HU (1) | HUP0303998A3 (no) |
IL (1) | IL157908A0 (no) |
MX (1) | MXPA03009583A (no) |
NO (1) | NO20034773L (no) |
NZ (1) | NZ529221A (no) |
PL (1) | PL363312A1 (no) |
SK (1) | SK14342003A3 (no) |
WO (1) | WO2002085906A2 (no) |
ZA (1) | ZA200308930B (no) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EA200300836A1 (ru) | 2001-02-15 | 2004-02-26 | Алтана Фарма Аг | Производные фталазинон-пиперидина в качестве ингибиторов pde4 |
CA2445236A1 (en) * | 2001-04-25 | 2002-10-31 | Altana Pharma Ag | Piperazino-derivatives and their use as pde4 inhibitor |
US20060094710A1 (en) * | 2002-08-10 | 2006-05-04 | Altana Pharma Ag | Piperidine-pyridazones and phthalazones as pde4 inhibitors |
AU2003255376A1 (en) * | 2002-08-10 | 2004-03-11 | Altana Pharma Ag | Piperidine-derivatives as pde4 inhibitors |
EP1556369A1 (en) * | 2002-08-10 | 2005-07-27 | ALTANA Pharma AG | Pyridazinone-derivatives as pde4 inhibitors |
CA2494643A1 (en) * | 2002-08-10 | 2004-03-04 | Altana Pharma Ag | Piperidine-n-oxide-derivatives |
DE602005005638T2 (de) * | 2004-02-04 | 2009-05-14 | Nycomed Gmbh | 2-(piperidin-4-yl)-4,5-dihydro-2h-pyridazin-3-on-derivate als pde4-inhibitoren |
US20080227790A1 (en) * | 2004-02-04 | 2008-09-18 | Altana Pharma Ag | Pyridazinone Derivatives and their Use as Pde4 Inhibitors |
EP1763528B1 (en) * | 2004-07-05 | 2008-11-26 | Astellas Pharma Inc. | Pyrazolopyridine derivatives |
AU2006240730A1 (en) * | 2005-04-21 | 2006-11-02 | Nippon Shinyaku Co., Ltd. | Phthalazinone derivative and pharmaceutical comprising the same |
ES2308916B1 (es) | 2007-03-22 | 2009-10-29 | Consejo Superior De Investigaciones Cientificas | Compuesto inhibidor dual de las enzimas pde7 y/o pde4, composiciones farmaceuticas y sus aplicaciones. |
CA2681650C (en) * | 2007-03-27 | 2016-11-22 | Omeros Corporation | The use of pde7 inhibitors for the treatment of movement disorders |
US8637528B2 (en) | 2007-03-27 | 2014-01-28 | Omeros Corporation | Use of PDE7 inhibitors for the treatment of movement disorders |
ES2374337T3 (es) | 2007-05-16 | 2012-02-15 | Nycomed Gmbh | Derivados de pirazolona como inhibidores de pde4. |
AR074318A1 (es) | 2008-11-14 | 2011-01-05 | Nycomed Gmbh | Derivados heterociclicos de pirazolona, composiciones farmaceuticas que los contienen y uso de los mismos para el tratamiento de enfermedades de las vias respiratorias. |
SG171765A1 (en) | 2008-11-20 | 2011-07-28 | Genentech Inc | Pyrazolopyridine pi3k inhibitor compounds and methods of use |
RU2661410C2 (ru) | 2010-11-08 | 2018-07-16 | Омерос Корпорейшн | Лечение зависимости и расстройства побуждений с применением ингибиторов фдэ7 |
US9220715B2 (en) | 2010-11-08 | 2015-12-29 | Omeros Corporation | Treatment of addiction and impulse-control disorders using PDE7 inhibitors |
HUE031652T2 (en) | 2011-02-07 | 2017-07-28 | Scipharm Sarl | New composition for treating cystic fibrosis |
KR20140037195A (ko) * | 2011-06-17 | 2014-03-26 | 다케다 게엠베하 | 신규 프탈라지논-피롤로피리미딘카복스아미드 유도체 |
EP2804603A1 (en) | 2012-01-10 | 2014-11-26 | President and Fellows of Harvard College | Beta-cell replication promoting compounds and methods of their use |
CN102964340B (zh) * | 2012-12-12 | 2015-10-07 | 中国药科大学 | 一类治疗阿尔茨海默病的选择性多巴胺d1受体激动剂 |
CN105307655B (zh) | 2013-03-13 | 2019-05-03 | 弗拉特利发现实验室有限责任公司 | 哒嗪酮化合物及其用于制备治疗囊肿状纤维化的药物的应用 |
CN112876460B (zh) * | 2021-02-05 | 2022-05-31 | 山西大学 | 7-二乙胺基-3-乙酰基香豆素衍生物及其合成方法和应用 |
WO2024038090A1 (en) | 2022-08-18 | 2024-02-22 | Mitodicure Gmbh | Use of substituted benzoxazole and benzofuran compounds for the treatment and prevention of diseases associated with chronic fatigue, exhaustion and/or exertional intolerance |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1993007146A1 (en) * | 1991-10-09 | 1993-04-15 | Syntex (U.S.A.) Inc. | Benzo and pyrido pyridazinone and pyridazinthione compounds with pde iv inhibiting activity |
US5716954A (en) | 1991-10-09 | 1998-02-10 | Syntex U.S.A. Inc. | Benzopyridazinone and pyridopyridazinone compounds |
ES2192192T3 (es) | 1992-12-02 | 2003-10-01 | Pfizer | Dieteres de catecol como inhibidores selectivos de pde iv. |
DE19533975A1 (de) | 1995-09-14 | 1997-03-20 | Merck Patent Gmbh | Arylalkyl-diazinone |
WO1998031674A1 (en) * | 1997-01-15 | 1998-07-23 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Phthalazinones |
CA2314111A1 (en) | 1997-12-15 | 1999-06-24 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Dihydrobenzofurans |
AU1760399A (en) | 1997-12-15 | 1999-07-05 | Byk Gulden Lomberg Chemische Fabrik Gmbh | New phthalazinones |
EP0934933A1 (en) | 1998-02-06 | 1999-08-11 | Byk Gulden Lomberg Chemische Fabrik GmbH | Phthalazinones |
CA2323771A1 (en) | 1998-03-14 | 1999-09-23 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Phthalazinone pde iii/iv inhibitors |
WO2001019818A1 (en) | 1999-09-14 | 2001-03-22 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Phthalazinone derivatives as pd3/4 inhibitors |
BR0014990A (pt) * | 1999-10-25 | 2002-06-18 | Byk Gulden Lomberg Chem Fab | Derivados de tetrahidrotiopirano ranftalazinona como inibidores de pde4 |
CA2388121A1 (en) | 1999-10-25 | 2001-05-03 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Phthalazinone derivatives as pde 4 inhibitors |
AU2001262332B2 (en) | 2000-06-05 | 2006-05-25 | Altana Pharma Ag | Compounds effective as beta-2-adrenoreceptor agonists as well as PDE4-inhibitors |
-
2002
- 2002-04-23 PL PL02363312A patent/PL363312A1/xx not_active Application Discontinuation
- 2002-04-23 IL IL15790802A patent/IL157908A0/xx unknown
- 2002-04-23 KR KR10-2003-7013937A patent/KR20040008162A/ko not_active Application Discontinuation
- 2002-04-23 CZ CZ20033206A patent/CZ299347B6/cs not_active IP Right Cessation
- 2002-04-23 EP EP02747291A patent/EP1385848A2/en not_active Withdrawn
- 2002-04-23 CN CNA028087429A patent/CN1503792A/zh active Pending
- 2002-04-23 MX MXPA03009583A patent/MXPA03009583A/es unknown
- 2002-04-23 US US10/475,657 patent/US7186710B2/en not_active Expired - Fee Related
- 2002-04-23 AU AU2002317733A patent/AU2002317733B2/en not_active Ceased
- 2002-04-23 EE EEP200300514A patent/EE200300514A/xx unknown
- 2002-04-23 SK SK1434-2003A patent/SK14342003A3/sk not_active Application Discontinuation
- 2002-04-23 NZ NZ529221A patent/NZ529221A/en unknown
- 2002-04-23 CA CA002445233A patent/CA2445233A1/en not_active Abandoned
- 2002-04-23 BR BR0209149-6A patent/BR0209149A/pt not_active Application Discontinuation
- 2002-04-23 EA EA200301100A patent/EA200301100A1/ru unknown
- 2002-04-23 JP JP2002583433A patent/JP2004526789A/ja not_active Withdrawn
- 2002-04-23 WO PCT/EP2002/004438 patent/WO2002085906A2/en active IP Right Grant
- 2002-04-23 HU HU0303998A patent/HUP0303998A3/hu unknown
-
2003
- 2003-10-24 NO NO20034773A patent/NO20034773L/no not_active Application Discontinuation
- 2003-10-24 HR HR20030868A patent/HRP20030868A2/xx not_active Application Discontinuation
- 2003-10-27 BG BG108294A patent/BG108294A/bg unknown
- 2003-11-17 ZA ZA200308930A patent/ZA200308930B/en unknown
Also Published As
Publication number | Publication date |
---|---|
KR20040008162A (ko) | 2004-01-28 |
IL157908A0 (en) | 2004-03-28 |
HRP20030868A2 (en) | 2005-08-31 |
HUP0303998A3 (en) | 2007-03-28 |
BG108294A (bg) | 2004-09-30 |
CZ299347B6 (cs) | 2008-06-25 |
CN1503792A (zh) | 2004-06-09 |
NO20034773L (no) | 2003-12-10 |
WO2002085906A2 (en) | 2002-10-31 |
SK14342003A3 (sk) | 2004-05-04 |
WO2002085906A3 (en) | 2002-12-19 |
EE200300514A (et) | 2004-02-16 |
HUP0303998A2 (hu) | 2004-05-28 |
BR0209149A (pt) | 2004-07-13 |
CA2445233A1 (en) | 2002-10-31 |
JP2004526789A (ja) | 2004-09-02 |
AU2002317733B2 (en) | 2007-12-13 |
MXPA03009583A (es) | 2004-02-12 |
EA200301100A1 (ru) | 2004-06-24 |
ZA200308930B (en) | 2004-06-09 |
CZ20033206A3 (cs) | 2004-02-18 |
US7186710B2 (en) | 2007-03-06 |
NZ529221A (en) | 2005-04-29 |
EP1385848A2 (en) | 2004-02-04 |
PL363312A1 (en) | 2004-11-15 |
US20040127707A1 (en) | 2004-07-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20035428D0 (no) | Nye anti-ineffektiver | |
NO20034992D0 (no) | Nye 4-aninlinokinolin-3-karboksamider | |
NO20034773D0 (no) | Nye ftalazinoner | |
NO20040014L (no) | Nye forbindelser | |
NO20041003L (no) | Nye forbindelser | |
NO20034665D0 (no) | Nye forbindelser | |
NO20034308L (no) | Nye tyrokinase-inhibitorer | |
NO20026064L (no) | Nye forbindelser | |
NO20023932L (no) | Nye forbindelser | |
NO20034970D0 (no) | Nye arylheteroalkylaminderivater | |
NO20044588L (no) | Nye forbindelser | |
NO20044432L (no) | Nye forbindelser | |
ATE402148T1 (de) | Substituierte pyridinylamine | |
DE60219284D1 (de) | Dreischichtige maschenware | |
DE50206892D1 (de) | Substituierte imidazotriazinone | |
NO20033679D0 (no) | Nye pyrimidinforbindelser | |
NO20025151D0 (no) | Nye forbindelser | |
NO20031141D0 (no) | Nye forbindelser | |
NO20040066L (no) | Nye antikonvulsivaderivater | |
NO20014597D0 (no) | Fremgangsmåte | |
NO20041185L (no) | Nye sykloheksylsulfoner | |
NO20026162D0 (no) | Nye forbindelser | |
DK1373228T3 (da) | Substituerede fluoralkoxyphenylsulfonylurinstoffer | |
IS2523B (is) | Turn vindorkuvers | |
NO20030274L (no) | Nye aryleten-sulfonamider |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |